Search Results

There are 12092 results for: content related to: Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen–negative chronic hepatitis B virus infection?

  1. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  2. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection

    Journal of Viral Hepatitis

    Volume 15, Issue 6, June 2008, Pages: 434–441, G. V. Papatheodoridis, N. Chrysanthos, E. Hadziyannis, E. Cholongitas and E. K. Manesis

    Version of Record online : 9 JAN 2008, DOI: 10.1111/j.1365-2893.2007.00957.x

  3. You have free access to this content
    Systematic review: cessation of long-term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen-negative chronic hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 3, August 2015, Pages: 243–257, M.-L. Chang, Y.-F. Liaw and S. J. Hadziyannis

    Version of Record online : 10 JUN 2015, DOI: 10.1111/apt.13272

  4. There were no differences in serum HBV DNA level between HBeAg-positive and HBeAg-negative chronic hepatitis B with same liver histological necroinflammation grade but differences among grades 1, 2, 3 and 4 apportioned by the same hepatic parenchyma cell volume

    Journal of Viral Hepatitis

    Volume 18, Issue 9, September 2011, Pages: 637–645, W.-M. Ke, S.-B. Xie, X.-J. Li, S.-Q. Zhang, J. Lai, Y.-N. Ye, Z.-L. Gao and P.-J. Chen

    Version of Record online : 24 MAR 2011, DOI: 10.1111/j.1365-2893.2011.01444.x

  5. You have free access to this content
    Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection

    Hepatology

    Volume 36, Issue 6, December 2002, Pages: 1408–1415, Chi-Jen Chu, Munira Hussain and Anna S. F. Lok

    Version of Record online : 7 MAR 2007, DOI: 10.1002/hep.1840360617

  6. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  7. Assessment of chronic hepatitis B: the importance of hepatitis B virus DNA testing

    Internal Medicine Journal

    Volume 42, Issue 2, February 2012, Pages: 170–175, C. M. N. Croagh, S. J. Bell, S. Locarnini and P. V. Desmond

    Version of Record online : 22 FEB 2012, DOI: 10.1111/j.1445-5994.2011.02435.x

  8. You have free access to this content
    Current management of chronic hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 19, Issue 1, January 2004, Pages: 25–37, G. V. Papatheodoridis and S. J. Hadziyannis

    Version of Record online : 27 NOV 2003, DOI: 10.1046/j.1365-2036.2003.01810.x

  9. You have free access to this content
    Chronic hepatitis B

    Hepatology

    Volume 45, Issue 2, February 2007, Pages: 507–539, Anna S. F. Lok and Brian J. McMahon

    Version of Record online : 26 JAN 2007, DOI: 10.1002/hep.21513

  10. You have free access to this content
    Abstracts 890 to 1096

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 632A–724A,

    Version of Record online : 19 SEP 2007, DOI: 10.1002/hep.22020

  11. Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg-negative patients

    Journal of Medical Virology

    Volume 82, Issue 9, September 2010, Pages: 1494–1500, L.Y. Lin, V.W.S. Wong, H.J. Zhou, H.Y. Chan, H.L. Gui, S.M. Guo, H. Wang, L. Huang, S.S. Bao, Q. Xie and H.L.Y. Chan

    Version of Record online : 15 JUL 2010, DOI: 10.1002/jmv.21863

  12. You have free access to this content
    HBeAg-negative chronic hepatitis B: why do I treat my patients with pegylated interferon-alfa?

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 127–132, Jiannis Vlachogiannakos and George V. Papatheodoridis

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12404

  13. You have free access to this content
    Hepatitis B e antigen–negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL

    Hepatology

    Volume 49, Issue 2, February 2009, Pages: 704–705, Chia-Yen Dai, Wan-Long Chuang, Jee-Fu Huang and Ming-Lung Yu

    Version of Record online : 5 NOV 2008, DOI: 10.1002/hep.22723

  14. You have free access to this content
    Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels

    Hepatology

    Volume 52, Issue 2, August 2010, Pages: 454–461, Vincent Rijckborst, Bettina E. Hansen, Yilmaz Cakaloglu, Peter Ferenci, Fehmi Tabak, Meral Akdogan, Krzysztof Simon, Ulus S. Akarca, Robert Flisiak, Elke Verhey, Anneke J. Van Vuuren, Charles A. B. Boucher, Martijn J. ter Borg and Harry L. A. Janssen

    Version of Record online : 19 APR 2010, DOI: 10.1002/hep.23722

  15. Viral Hepatitis

    Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition

    Mario Rizzetto, Fabien Zoulim, Pages: 819–956, 2008

    Published Online : 15 APR 2008, DOI: 10.1002/9780470691861.ch9a

  16. On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients

    Liver International

    Volume 35, Issue 5, May 2015, Pages: 1540–1548, Ioannis Goulis, Stylianos Karatapanis, Evangelos Akriviadis, Melanie Deutsch, George N. Dalekos, Maria Raptopoulou-Gigi, Konstantinos Mimidis, George Germanidis, Christos Drakoulis, Christos Triantos, Elias Zintzaras, Georgios Bakalos and George Papatheodoridis

    Version of Record online : 20 NOV 2014, DOI: 10.1111/liv.12725

  17. Impact of interferon-alpha therapy on liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 12, Issue 2, March 2005, Pages: 199–206, G. V. Papatheodoridis, K. Petraki, E. Cholongitas, E. Kanta, I. Ketikoglou and E. K. Manesis

    Version of Record online : 17 FEB 2005, DOI: 10.1111/j.1365-2893.2005.00582.x

  18. Serum HBsAg kinetics and usefulness of interferon-inducible protein 10 serum in HBeAg-negative chronic hepatitis B patients treated with tenofovir disoproxil fumarate

    Journal of Viral Hepatitis

    Volume 22, Issue 12, December 2015, Pages: 1079–1087, G. Papatheodoridis, C. Triantos, E. Hadziyannis, K. Zisimopoulos, A. Georgiou, T. Voulgaris, I. Vlachogiannakos, V. Nikolopoulou and S. Manolakopoulos

    Version of Record online : 6 JUL 2015, DOI: 10.1111/jvh.12434

  19. You have free access to this content
    Serum M30 levels: A potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels

    Hepatology

    Volume 49, Issue 2, February 2009, Page: 697, Yusuf Yilmaz, Engin Ulukaya and Enver Dolar

    Version of Record online : 13 NOV 2008, DOI: 10.1002/hep.22691

  20. You have free access to this content
    AASLD Abstracts 895–1142

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 707A–816A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22644